HomeFileCoronary disease

Coronary disease

View Category

Chronic Ischemic cardiopathy

IVUS vs OCT to Guide PCI: Which Should We Choose?

Controlling stent expansion with optical coherence tomography (OCT) based on an external elastic membrane–based protocol for stent...
solaci -
Learn More
Coronary disease

27/04 | SOLACI / BIOTRONIK Webinar

We invite you to participate in a new SOLACI virtual event open to the entire community. It...
solaci -
Learn More
Chronic Ischemic cardiopathy

The Future of Prevention? Stenting Vulnerable Fractional FFR Negative Lesions

For many patients, the first symptom of heart disease is acute MI, or even sudden death.  Changes in...
solaci -
Learn More
Acute coronary syndromes

Post MI Betablockers for Good?

Patients receiving optimal medical treatment after MI do not seem to benefit from betablockers in the long...
solaci -
Learn More
Chronic Ischemic cardiopathy

Impact of FFR After Stenting: Useful or Mere Fun Fact?

Suboptimal fractional flow reserve (FFR) results after stenting only have a moderate impact on clinical hard points...
solaci -
Learn More
Antiplatelet

Short Therapy and Monotherapy, Plenty of Evidence

A short dual antiplatelet therapy (DAPT) of 1 to 3 months followed by P2Y12 inhibitor monotherapy after...
solaci -
Learn More
Coronary disease

Lower Mortality with Rechanneling vs. Medical Therapy

We had to wait for it, but we have finally seen a benefit in hard endpoints—such as...
solaci -
Learn More
Acute coronary syndromes

Biodegradable Polymer Myth Also Debunked for ACSs

During TCT 2020 a preview of the results of the comparison of drug-eluting stents (DES) with biodegradable-polymer vs....
solaci -
Learn More